Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans.
about
Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.Phytate: impact on environment and human nutrition. A challenge for molecular breedingPhytic acid as a potential treatment for alzheimer's pathology: evidence from animal and in vitro models.Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.Renal lithiasis and nutrition.Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study.The behaviour of myo-inositol hexakisphosphate in the presence of magnesium(II) and calcium(II): protein-free soluble InsP6 is limited to 49 microM under cytosolic/nuclear conditions.Do mammals make all their own inositol hexakisphosphate?Phytate in pig and poultry nutrition.Fibrinogen - a possible extracellular target for inositol phosphates.There is no 'Conundrum' of InsP6.Conundrum of IP6.Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis.Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders.Soy, Soy Foods and Their Role in Vegetarian Diets.Characterization of deposits in patients with calcific tendinopathy of the supraspinatus. Role of phytate and osteopontin.The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats.Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.
P2860
Q30819492-74F07189-73EB-420F-8A3A-B52AAAEE5A2BQ34010593-2BAD9A85-AEC7-4C3F-830B-7BD209D02507Q34490302-07D51D45-B98A-44D2-85B7-4924FFA3FEF5Q34928606-EB4F62A6-0584-4112-901C-141D0AEC8B13Q35062389-C2E393FA-582C-47CD-AC86-86DBB95AF5B8Q35760476-5AAB4D6D-AA6E-4873-B939-803F19FF5971Q35803574-28338835-F1FC-46B2-B83C-045DA5DED797Q37021480-1BFE526C-BC1D-4672-91A3-795F5D6EEAC1Q38269099-FD24653F-511E-423A-8E73-9F7406D273E2Q38782892-D1B58B99-7570-4DF3-BB2D-F2D339D77C07Q43090438-497BFE97-F6BF-47F5-A96E-CB1153A36321Q43127586-ECC9C17C-E971-492F-8D62-C19B9A0F5372Q46283784-CD988362-FF97-49FF-A5EF-85751A4A3345Q47162682-33538D7C-9EA7-4C97-AF20-081D6976A4A5Q47230001-0B5949F2-DB95-449A-959F-EAC86245E503Q47776076-1374B9E5-9C4B-4386-B40F-08D44152FBBAQ51283700-6362A1B4-9AEF-4D84-8DFC-63E853CE832AQ55454896-369BB6CD-2589-4D63-8E8B-E11CC9881C10
P2860
Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@ast
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@en
Absorption and excretion of orally administered inositol hexaphosphate
@nl
type
label
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@ast
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@en
Absorption and excretion of orally administered inositol hexaphosphate
@nl
prefLabel
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@ast
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@en
Absorption and excretion of orally administered inositol hexaphosphate
@nl
P2093
P2860
P356
P1433
P1476
Absorption and excretion of or ...... (IP(6) or phytate) in humans.
@en
P2093
Costa-Bauzá A
Shamsuddin AM
Simonet BM
P2860
P356
10.1002/BIOF.5520150105
P577
2001-01-01T00:00:00Z